Loading viewer...
earnings
Format: PDF earnings
Henlius reports first-half 2022 financial and operational results, covering commercial operations, innovative biologics R&D progress, biosimilar development milestones, and manufacturing capacity expansion. The presentation details clinical and pre-clinical phase advancements in biopharmaceutical development.
annual_report
44 Pages
earnings
24 Pages
Canadian Tire Corporation
MarketAxess 3Q16 Earnings Conference Call 2016
earningsearnings
12 Pages
MarketAxess Holdings
Bega Cheese FY2023 Results Presentation 2023
earningsearnings
18 Pages
Bega Cheese Limited